Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Mallinckrodt and Endo, drugmakers with a shared history of facing bankruptcy and U.S. opioid litigation, have agreed to merge ...
BioSpace4d
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the ...
Fierce Pharma4d
Mallinckrodt, Endo look to carve out brighter future through $6.7B merger
Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the ...
Drugmakers Mallinckrodt, Endo agree to merge in nearly $7 billion deal
Endo shareholders will get $80 million in cash and own 49.9 per cent of the combined company, while Mallinckrodt shareholders ...
Reuters4d
Drugmakers Mallinckrodt, Endo in talks to merge, source says
While Mallinckrodt emerged from its second bankruptcy in November 2023, Endo returned last year. The drugmakers are discussing the terms of a transaction that would give each of them roughly 50% ...
Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S ...
Mallinckrodt and Endo plan merger as they look to recover from opioid litigation
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in ...